Original article
Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy
Impacto de la modificación de la respuesta inmunitaria por la lisofosfatidilcolina en la eficacia de la terapia antibiótica en un modelo experimental de sepsis peritoneal y de neumonía por Pseudomonas aeruginosa
Raquel Parra-Millána,1, Manuel E. Jiménez-Mejíasa,1,
, Rafael Ayerbe-Algabaa, Juan Domínguez-Herreraa, Caridad Díazb, José Pérez del Palaciob, Jerónimo Pachóna, Younes Smania
Corresponding author
a Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain
b Fundación Centro De Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Fundación MEDINA, Granada, Spain
Read
862
Timeswas read the article
165
Total PDF
697
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 33 | 5 | 38 |
| 2025 5 | 23 | 4 | 27 |
| 2025 4 | 15 | 4 | 19 |
| 2025 3 | 30 | 5 | 35 |
| 2025 2 | 32 | 2 | 34 |
| 2025 1 | 38 | 2 | 40 |
| 2024 12 | 21 | 4 | 25 |
| 2024 11 | 14 | 3 | 17 |
| 2024 10 | 15 | 9 | 24 |
| 2024 9 | 17 | 5 | 22 |
| 2024 8 | 17 | 4 | 21 |
| 2024 7 | 13 | 7 | 20 |
| 2024 6 | 13 | 2 | 15 |
| 2024 5 | 18 | 1 | 19 |
| 2024 4 | 11 | 6 | 17 |
| 2024 3 | 20 | 6 | 26 |
| 2024 2 | 22 | 2 | 24 |
| 2024 1 | 10 | 3 | 13 |
| 2023 12 | 14 | 1 | 15 |
| 2023 11 | 23 | 1 | 24 |
| 2023 10 | 27 | 4 | 31 |
| 2023 9 | 23 | 2 | 25 |
| 2023 8 | 15 | 0 | 15 |
| 2023 7 | 20 | 2 | 22 |
| 2023 6 | 20 | 3 | 23 |
| 2023 5 | 37 | 1 | 38 |
| 2023 4 | 36 | 0 | 36 |
| 2023 3 | 31 | 4 | 35 |
| 2023 2 | 20 | 1 | 21 |
| 2023 1 | 6 | 6 | 12 |
| 2022 12 | 10 | 3 | 13 |
| 2022 11 | 11 | 7 | 18 |
| 2022 10 | 10 | 5 | 15 |
| 2022 9 | 8 | 24 | 32 |
| 2022 8 | 9 | 21 | 30 |
| 2022 7 | 15 | 6 | 21 |
Show all
